Terms: = Bone cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1
145 results:
1. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and rar-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
2. Exosomal miR-181a-5p derived from SAOS-2 cells promotes macrophages M2 polarization by targeting RORA.
Wang ZG; Deng MS; Su JQ; Liu DB; Zhou Y
Kaohsiung J Med Sci; 2023 Feb; 39(2):124-133. PubMed ID: 36468636
[TBL] [Abstract] [Full Text] [Related]
3. rarγ: The bone of Contention for Endothelial Cells in Prostate cancer Metastasis.
Bhowmick S; Bhowmick NA
Cancer Res; 2022 Sep; 82(17):2975-2976. PubMed ID: 36052494
[TBL] [Abstract] [Full Text] [Related]
4. bone marrow overexpression of SNAI1 is an early indicator of intrinsic drug resistance in patients with de novo acute myeloid leukemia.
Gouda MBY; Hassan NM; Kandil EI
J Gene Med; 2023 May; 25(5):e3443. PubMed ID: 35900907
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-125b Accelerates and Promotes PML-rara-driven Murine Acute Promyelocytic Leukemia.
Guo B; Qin R; Chen JJ; Pan W; Lu XC
Biomed Environ Sci; 2022 Jun; 35(6):485-493. PubMed ID: 35882408
[TBL] [Abstract] [Full Text] [Related]
6. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.
Leguit RJ; Orazi A; Kucine N; Kvasnicka HM; Gianelli U; Arber DA; Porwit A; Ponzoni M
Virchows Arch; 2022 Oct; 481(4):621-646. PubMed ID: 35819517
[TBL] [Abstract] [Full Text] [Related]
7. Retinoic Acid Receptor Activation Reduces Metastatic Prostate cancer bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
[TBL] [Abstract] [Full Text] [Related]
8. Identification of variant APL translocations PRKAR1A-rarα and ZBTB16-rarα (PLZF-rarα) through the MI-ONCOSEQ platform.
King D; Foucar CE; Ma V; Benitez L; Perissinotti AJ; Marini BL; Robinson D; Bhave RR; Bixby D
Cancer Genet; 2021 Nov; 258-259():57-60. PubMed ID: 34534739
[TBL] [Abstract] [Full Text] [Related]
9. RBCK1-TRIB3 decelerated the progression of acute promyelocytic leukemia.
Zhang X; Yu W
Hematol Oncol; 2021 Oct; 39(4):567-569. PubMed ID: 34310740
[TBL] [Abstract] [Full Text] [Related]
10. Mutational profile of ZBTB16-rara-positive acute myeloid leukemia.
Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
[TBL] [Abstract] [Full Text] [Related]
11. [Therapy-related acute promyelocytic leukemia with complex karyotype accompanied by cryptic PML/rara on chromosome 15 by metaphase FISH].
Kashima E; Sugimoto Y; Nato Y; Ino K; Tawara I; Masuya M; Katayama N
Rinsho Ketsueki; 2020; 61(11):1577-1583. PubMed ID: 33298649
[TBL] [Abstract] [Full Text] [Related]
12. Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience.
Boeri L; Sharma V; Kwon E; Stish BJ; Davis BJ; Karnes RJ
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):514-523. PubMed ID: 33268854
[TBL] [Abstract] [Full Text] [Related]
13. [Therapy-related acute promyelocytic leukemia developing during chemotherapy for thymic carcinoma].
Amino I; Maeda T; Aoki M; Kinoshita H; Muroya A; Taji Y; Kobayashi K; Okamura D; Murayama Y; Asou N; Ebihara Y
Rinsho Ketsueki; 2020; 61(8):874-878. PubMed ID: 32908049
[TBL] [Abstract] [Full Text] [Related]
14. No prognostic significance of normalized copy number of PML-rara transcript at diagnosis in patients with acute promyelocytic leukemia.
Rasekh EO; Elsayed GM; Fathy S
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):119-125. PubMed ID: 32735792
[TBL] [Abstract] [Full Text] [Related]
15. Successful Treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.
Suzuki R; Kawai H; Furuya D; Akashi H; Ogawa Y; Kawada H; Ando K
Tokai J Exp Clin Med; 2020 Jul; 45(2):92-96. PubMed ID: 32602108
[TBL] [Abstract] [Full Text] [Related]
16. Fertility in female cancer survivors: a systematic review and meta-analysis.
Busnelli A; Vitagliano A; Mensi L; Acerboni S; Bulfoni A; Filippi F; Somigliana E
Reprod Biomed Online; 2020 Jul; 41(1):96-112. PubMed ID: 32456969
[TBL] [Abstract] [Full Text] [Related]
17. The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia.
Conserva MR; Anelli L; Zagaria A; Specchia G; Albano F
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207999
[TBL] [Abstract] [Full Text] [Related]
18. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
[TBL] [Abstract] [Full Text] [Related]
19. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.
Gaillard C; Surianarayanan S; Bentley T; Warr MR; Fitch B; Geng H; Passegué E; de Thé H; Kogan SC
Blood Adv; 2018 Oct; 2(19):2462-2466. PubMed ID: 30266821
[TBL] [Abstract] [Full Text] [Related]
20. Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway.
Chen JC; Huang C; Lee IN; Wu YP; Tang CH
Mol Carcinog; 2018 Dec; 57(12):1816-1824. PubMed ID: 30230033
[TBL] [Abstract] [Full Text] [Related]
[Next]